Enterprise Value
0.00
Cash
123.6M
Avg Qtr Burn
N/A
Short % of Float
0.12%
Insider Ownership
27.73%
Institutional Own.
8.75%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Marzeptacog alfa (MarzAA) Details Hemophilia, Blood disorder, Rare genetic disease | Failed Discontinued | |
SQ Dalcinonacog alfa (DalcA) Details Hemophilia, Genetic disorder | Failed Discontinued |